The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy ; volume:15 ; number:5 ; day:8 ; month:10 ; year:2013 ; pages:1-10 ; date:10.2013
Breast cancer research ; 15, Heft 5 (8.10.2013), 1-10, 10.2013
- Classification
-
Medizin, Gesundheit
- Creator
- Contributor
-
Taran, Florin-Andrei
Wallwiener, Markus
Hagenbeck, Carsten
Melcher, Carola
Krawczyk, Natalia
Hahn, Markus
Wallwiener, Diethelm
Fehm, Tanja
SpringerLink (Online service)
- DOI
-
10.1186/bcr3496
- URN
-
urn:nbn:de:101:1-2018081114272849681114
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hartkopf, Andreas
- Taran, Florin-Andrei
- Wallwiener, Markus
- Hagenbeck, Carsten
- Melcher, Carola
- Krawczyk, Natalia
- Hahn, Markus
- Wallwiener, Diethelm
- Fehm, Tanja
- SpringerLink (Online service)
Other Objects (12)
Circulating and Disseminated Tumor Cells in Breast Carcinoma : Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019
Circulating and Disseminated Tumour Cells in Breast Carcinoma : Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
The impact of single tumor cell dissemination on individualized systemic breast cancer treatment
Tucatinib (Tukysa) bei HER2-positivem Brustkrebs : hochwirksame Behandlungsoption für metastasierte Patienten, auch bei ZNS-Metastasierung
Trastuzumab-Deruxtecan (Enhertu) - Paradigmenwechsel: neue Optionen bei der Behandlung von Patient*innen mit nicht operablem, metastasiertem HER2-low Mammakarzinom
The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Trastuzumab deruxtecan (Enhertu®) : Paradigmenwechsel: neue Optionen bei der Behandlung von Patient*innen mit nicht operablem, metastasiertem HER2-low Mammakarzinom
Liquid Biopsy beim Mammakarzinom
Expression von Stammzellproteinen auf disseminierten Tumorzellen und korrespondierenden Primärtumoren bei Mammakarzinompatientinnen mit neoadjuvanter Chemotherapie als Resistenzmarker
Liquid Biopsy in Breast Cancer
Circulating and Disseminated Tumor Cells in Breast Carcinoma : Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019
Circulating and Disseminated Tumour Cells in Breast Carcinoma : Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
The impact of single tumor cell dissemination on individualized systemic breast cancer treatment
Tucatinib (Tukysa) bei HER2-positivem Brustkrebs : hochwirksame Behandlungsoption für metastasierte Patienten, auch bei ZNS-Metastasierung
Trastuzumab-Deruxtecan (Enhertu) - Paradigmenwechsel: neue Optionen bei der Behandlung von Patient*innen mit nicht operablem, metastasiertem HER2-low Mammakarzinom
The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Trastuzumab deruxtecan (Enhertu®) : Paradigmenwechsel: neue Optionen bei der Behandlung von Patient*innen mit nicht operablem, metastasiertem HER2-low Mammakarzinom
Liquid Biopsy beim Mammakarzinom
Expression von Stammzellproteinen auf disseminierten Tumorzellen und korrespondierenden Primärtumoren bei Mammakarzinompatientinnen mit neoadjuvanter Chemotherapie als Resistenzmarker
Liquid Biopsy in Breast Cancer
Circulating and Disseminated Tumor Cells in Breast Carcinoma : Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019
Circulating and Disseminated Tumour Cells in Breast Carcinoma : Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
The impact of single tumor cell dissemination on individualized systemic breast cancer treatment
Tucatinib (Tukysa) bei HER2-positivem Brustkrebs : hochwirksame Behandlungsoption für metastasierte Patienten, auch bei ZNS-Metastasierung
Trastuzumab-Deruxtecan (Enhertu) - Paradigmenwechsel: neue Optionen bei der Behandlung von Patient*innen mit nicht operablem, metastasiertem HER2-low Mammakarzinom
The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Trastuzumab deruxtecan (Enhertu®) : Paradigmenwechsel: neue Optionen bei der Behandlung von Patient*innen mit nicht operablem, metastasiertem HER2-low Mammakarzinom
Liquid Biopsy beim Mammakarzinom
Expression von Stammzellproteinen auf disseminierten Tumorzellen und korrespondierenden Primärtumoren bei Mammakarzinompatientinnen mit neoadjuvanter Chemotherapie als Resistenzmarker